Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02616640
Title A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene Corporation
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | ITA | FRA | ESP | DEU | CAN

Facility Status City State Zip Country Details
Local Institution - 102 Baltimore Maryland 21231 United States Details
Local Institution - 114 Boston Massachusetts 02114 United States Details
Local Institution - 108 Boston Massachusetts 02115 United States Details
Local Institution - 115 Boston Massachusetts 02215 United States Details
Local Institution - 105 New York New York 10065 United States Details
Local Institution - 106 Charlotte North Carolina 28204 United States Details
Local Institution - 110 Cleveland Ohio 44195 United States Details
Local Institution - 107 Milwaukee Wisconsin 53226 United States Details
Local Institution - 201 Calgary Alberta T2N 4N2 Canada Details
Local Institution - 601 Lille 59037 France Details
Local Institution - 602 Poitiers Cedex 86021 France Details
Local Institution - 603 Toulouse CEDEX 9 31059 France Details
Local Institution - 301 Tuebingen 72076 Germany Details
Local Institution - 403 Pavia 2 27100 Italy Details
Local Institution - 405 Rozzano (MI) 20089 Italy Details
Local Institution - 401 Torino 10126 Italy Details
Local Institution - 702 Amsterdam 1081 HV Netherlands Details
Local Institution - 701 Rotterdam 3015 CN Netherlands Details
Local Institution - 501 Barcelona 08916 Spain Details
Local Institution - 504 Madrid 28041 Spain Details
Local Institution - 502 Pamplona 31008 Spain Details
Local Institution - 505 Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field